187 related articles for article (PubMed ID: 29921209)
1. Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification.
Makri OE; Tsekouras IK; Plotas P; Tsapardoni F; Pallikari A; Georgakopoulos CD
Curr Drug Saf; 2018; 13(3):208-210. PubMed ID: 29921209
[TBL] [Abstract][Full Text] [Related]
2. Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature.
Makri OE; Tsapardoni FN; Plotas P; Ifantis N; Xanthopoulou PT; Georgakopoulos CD
BMC Res Notes; 2017 Mar; 10(1):127. PubMed ID: 28320481
[TBL] [Abstract][Full Text] [Related]
3. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery.
Altintaş O; Yüksel N; Karabaş VL; Demirci G
Eur J Ophthalmol; 2005; 15(1):158-61. PubMed ID: 15751259
[TBL] [Abstract][Full Text] [Related]
4. Cystoid macular edema associated with latanoprost therapy in a pseudophakic vitrectomized patient after removal of silicone oil endotamponade.
Jäger M; Jonas JB
Eur J Ophthalmol; 2003 Mar; 13(2):221-2. PubMed ID: 12696646
[TBL] [Abstract][Full Text] [Related]
5. Latanoprost-associated cystoid macular edema.
Callanan D; Fellman RL; Savage JA
Am J Ophthalmol; 1998 Jul; 126(1):134-5. PubMed ID: 9683162
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
7. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation.
Yeh PC; Ramanathan S
J Cataract Refract Surg; 2002 Oct; 28(10):1814-8. PubMed ID: 12388034
[TBL] [Abstract][Full Text] [Related]
8. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
McCafferty S; Harris A; Kew C; Kassm T; Lane L; Levine J; Raven M
BMC Ophthalmol; 2017 Feb; 17(1):16. PubMed ID: 28219426
[TBL] [Abstract][Full Text] [Related]
9. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
10. A case of cystoid macular edema associated with latanoprost ophthalmic solution.
Tokunaga T; Kashiwagi K; Saito J; Kobayashi K; Kobori Y; Abe K; Tsukahara S
Jpn J Ophthalmol; 2002; 46(6):656-9. PubMed ID: 12543193
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
[TBL] [Abstract][Full Text] [Related]
12. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
Warren KA; Fox JE
Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
[TBL] [Abstract][Full Text] [Related]
13. Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications.
Watanabe K; Hayasaka S; Hayasaka Y; Nagaki Y; Watanabe K
Jpn J Ophthalmol; 2003; 47(1):110-2. PubMed ID: 12586189
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
[TBL] [Abstract][Full Text] [Related]
15. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost.
Lima MC; Paranhos A; Salim S; Honkanen R; Devgan L; Wand M; Gaudio AR; Shields MB
J Glaucoma; 2000 Aug; 9(4):317-21. PubMed ID: 10958605
[TBL] [Abstract][Full Text] [Related]
16. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
[TBL] [Abstract][Full Text] [Related]
17. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
18. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
Mathys KC; Cohen KL
Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
[TBL] [Abstract][Full Text] [Related]
19. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.
Ayyala RS; Cruz DA; Margo CE; Harman LE; Pautler SE; Misch DM; Mines JA; Richards DW
Am J Ophthalmol; 1998 Oct; 126(4):602-4. PubMed ID: 9780112
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
El Gharbawy SA; Darwish EA; Abu Eleinen KG; Osman MH
Eur J Ophthalmol; 2019 Jul; 29(4):453-457. PubMed ID: 30203671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
